Nurix Therapeutics, Inc. (NRIX) Financials
NRIX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2024-02-29 | 312.7 million | 143.9 million |
2023-11-30 | 364.5 million | 164.0 million |
2023-08-31 | 308.2 million | 74.4 million |
2023-05-31 | 350.6 million | 90.7 million |
NRIX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2024-02-29 | -44.8 million | 7.8 million |
2023-11-30 | 19.2 million | 8.0 million |
2023-08-31 | -43.6 million | 8.4 million |
2023-05-31 | -19.5 million | 8.7 million |
NRIX Net Income
No data available :(
NRIX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2024-02-29 | 244.0 million | - | 29.2 million |
2023-11-30 | 287.9 million | - | 30.6 million |
2023-08-31 | 258.9 million | - | 8.0 million |
2023-05-31 | 281.2 million | - | 9.3 million |
NRIX Shares Outstanding
NRIX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2024-02-29 | 2.9 million | 48.0 million | 11.8 million | 1.8 million |
2023-11-30 | 2.6 million | 47.8 million | 10.8 million | 1.8 million |
2023-08-31 | 2.5 million | 47.9 million | 10.6 million | - |
2023-05-31 | 1.1 million | 45.8 million | 11.7 million | - |
NRIX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2024-02-29 | 16.6 million | 3.9 million |
2023-11-30 | 15.2 million | 3.8 million |
2023-08-31 | 18.5 million | 3.4 million |
2023-05-31 | 30.7 million | 3.3 million |
NRIX
Price: $12.78
52 week price:
Earnings Per Share: -2.65 USD
P/E Ratio: -2.97
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 161700
Market Capitalization: 720.1 million